![Alyssa Levin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alyssa Levin
Keine laufenden Positionen mehr
Vermögen: 290 533 $ am 30.06.2026
Profil
Alyssa Levin formerly worked at ViaCyte, Inc., as Chief Financial Officer, Bird Rock Bio Sub, Inc., as Chief Financial Officer from 2019 to 2020, Tentarix Biotherapeutics, Inc., as Chief Financial Officer & Senior VP-Operations from 2020 to 2022, and Nkarta, Inc., as Chief Financial & Business Officer from 2023 to 2025.
Ms. Levin received her undergraduate degree from the University of British Columbia and graduate degree from Edwards School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NKARTA, INC. 0,14 % | 15.01.2025 | 102.662 ( 0,14 % ) | 290 533 $ | 30.06.2026 |
Ehemalige bekannte Positionen von Alyssa Levin
| Unternehmen | Position | Ende |
|---|---|---|
| NKARTA, INC. | Finanzdirektor/CFO | 31.03.2025 |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Finanzdirektor/CFO | 05.07.2023 |
Tentarix Biotherapeutics, Inc.
 Tentarix Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company for intelligent therapies with multifunctional biologics | Finanzdirektor/CFO | 02.01.2022 |
Bird Rock Bio Sub, Inc.
 Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Finanzdirektor/CFO | 02.01.2020 |
Ausbildung von Alyssa Levin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
2
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bird Rock Bio Sub, Inc.
Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Edwards School of Business
 Edwards School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nkarta, Inc.
 Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment | Health Technology |
Tentarix Biotherapeutics, Inc.
Tentarix Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company for intelligent therapies with multifunctional biologics | Health Technology |
